IMFINZI is a programmed death-ligand 1 (PD-L1) blocking antibody indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma
IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.
For procurement cost of IMFINZI (durvalumab) injection brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the IMFINZI (durvalumab) injection tablets cost price in India.
The order for IMFINZI (durvalumab) injection will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Durvalumab (trade name Imfinzi) is an FDA-approved immunotherapy for cancer, developed by Medimmune/AstraZeneca. It is a human immunoglobulin G1 kappa (IgG1κ) monoclonal antibody that blocks the interaction of programmed cell death ligand 1 (PD-L1) with the PD-1 (CD279). Durvalumab is approved for the treatment of patients with locally advanced or metastatic urothelial carcinoma who either have disease progression during or following platinum-containing chemotherapy or have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy.
IMFINZI (durvalumab) injection tablets, for oral use. Initial U.S. Approval: 2017
Generic Name: durvalumab
Injection: 500 mg/10mL (50 mg/mL) solution in a single-dose vial.
Injection: 120 mg/2.4mL (50 mg/mL) solution in a single-dose vial.
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand IMFINZI (durvalumab) injection on prescription and Import License in Patient's Name only.
For overseas patients, IMFINZI (durvalumab) injection can be made available in Send your enquiry to find IMFINZI (durvalumab) injection in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For IMFINZI (durvalumab) injection Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details
AstraZeneca wins speedy FDA review for Imfinzi to challenge Roche in small cell lung cancer For More Details
Immunotherapy Drug Improves Survival, Lasting Responses for Extensive-Stage SCLC For More Details